GILD

Gilead Sciences, Inc.

Gilead Sciences Inc is a biopharmaceutical company that discovers, develops and commercializes new medicines in areas of unmet medical need. Its products target a number of areas, such as HIV, liver diseases, cardiovascular and other diseases.

Gilead Sciences, Inc. (GILD) is scored daily on Deltasharpe Prism against Healthcare sector peers across five pillars: Value, Growth, Profitability, Momentum and Revisions.

Quantitative Factor Evaluation • Updated

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Historical Factor Score Progression

Date Value Growth Profitability Momentum Revisions Overall
2026-11-16 B- (3.0) C- (1.9) B+ (3.7) B+ (3.8) C (2.4) B- (3.0)
2026-11-09 B- (3.0) C- (1.9) B+ (3.7) B+ (3.7) C (2.4) B- (3.0)
2026-11-07 B- (3.0) C- (1.9) B+ (3.8) B+ (3.7) C (2.5) B- (3.0)
2026-11-05 B- (3.0) C- (1.9) B+ (3.8) B+ (3.7) C (2.4) B- (3.0)
2026-11-02 B- (3.0) C- (1.9) B+ (3.8) B+ (3.6) C+ (2.6) B- (3.0)
Page 1 of 3

Showing the last month only. Subscribe for the full factor score history.

For more — Subscribe